We have previously reported that prolonged exposure to FGF19 delivered via recombinant AAV induces HCC in db/db and multidrug resistance 2 (MDR2)-deficient mice (Mdr2−/−)12, 37. The gene discussed is ABCB4; the disease is hepatocellular carcinoma.